Rosenblum, PhD, A., Cruciani, MD, PhD, R. A., Strain, MD, E. C., Cleland, PhD, C. M., Joseph, PhD, H., Magura, PhD, CSW, S., Marsch, PhD, L. A., McNicholas, MD, PhD, L. F., Savage, MD, MS, S. R., Sundaram, BA, A., & Portenoy, MD, R. K. (2012). Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: Development and pilot test of a clinical protocol. Journal of Opioid Management, 8(6), 369–382. https://doi.org/10.5055/jom.2012.0137a